BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 29769144)

  • 21. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.
    Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T
    Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis.
    Gilcrease MZ; Kilpatrick SK; Woodward WA; Zhou X; Nicolas MM; Corley LJ; Fuller GN; Tucker SL; Diaz LK; Buchholz TA; Frost JA
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):80-6. PubMed ID: 19124484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
    Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
    Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hic-5 remodeling of the stromal matrix promotes breast tumor progression.
    Goreczny GJ; Ouderkirk-Pecone JL; Olson EC; Krendel M; Turner CE
    Oncogene; 2017 May; 36(19):2693-2703. PubMed ID: 27893716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
    McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
    Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
    Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL
    Oncogene; 2006 Aug; 25(36):4998-5010. PubMed ID: 16568086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
    Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR
    PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of
    Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
    Ma Z; Gibson SL; Byrne MA; Zhang J; White MF; Shaw LM
    Mol Cell Biol; 2006 Dec; 26(24):9338-51. PubMed ID: 17030605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of ASAP1 in the MMTV-PyMT model of luminal breast cancer activates AKT, accelerates tumorigenesis, and promotes metastasis.
    Schreiber C; Gruber A; Roßwag S; Saraswati S; Harkins S; Thiele W; Foroushani ZH; Munding N; Schmaus A; Rothley M; Dimmler A; Tanaka M; Garvalov BK; Sleeman JP
    Cancer Lett; 2022 May; 533():215600. PubMed ID: 35181478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.
    Zhang Y; Xia P; Zhang W; Yan M; Xiong X; Yu W; Song E
    Hum Pathol; 2017 Jul; 65():113-122. PubMed ID: 28511963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.
    Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J
    Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.
    Cook LM; Cao X; Dowell AE; Debies MT; Edmonds MD; Beck BH; Kesterson RA; Desmond RA; Frost AR; Hurst DR; Welch DR
    Clin Exp Metastasis; 2012 Apr; 29(4):315-25. PubMed ID: 22241150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
    Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
    Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
    Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
    Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
    Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.